Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Medicine (Baltimore) ; 102(31): e34563, 2023 Aug 04.
Article in English | MEDLINE | ID: mdl-37543773

ABSTRACT

To investigate the prognostic role of the elevated aspartate and alanine aminotransferase (AST/ALT) ratio in patients with unstable angina (UA). In this observational study, all patients with UA undergoing percutaneous coronary intervention at our center from January 2019 to December 2020 were examined. Clinical presentations, laboratory parameters, and procedural characteristics were collected. The primary endpoint was a composite of major adverse cardio-cerebral events (MACCE), such as death, nonfatal myocardial infarction, nonfatal stroke, and target vessel revascularization. In total, 1123 eligible UA patients were enrolled in the present study (mean age 62.3 years; 54.5% of male). Patients in the upper tertile of the AST/ALT ratio were older, had more extensive coronary stenosis, and had poor nutritional status (P < .05). Meanwhile, the cumulative incidence of MACCE at 13 months of follow-up increased in a stepwise manner and across the tertile of the AST/ALT ratio, predominantly driven by target vessel revascularization (both log-rank P < .001). Importantly, the AST/ALT ratio was associated with MACCE in a multivariate analysis that was adjusted for potential covariates (hazard ratio 1.72, 95% confidence interval 1.48-1.99, P < .01). The optimal cutoff point of the AST/ALT ratio to predict MACCE was 1.29 (area under the curve 0.77, 95% confidence interval 0.69-0.84, P < .001), with sensitivity and specificity of 77.5% and 65.1%, respectively. The increased AST/ALT ratio, especially when above 1.29, is associated with MACCE in patients with UA undergoing percutaneous coronary intervention.


Subject(s)
Coronary Artery Disease , Percutaneous Coronary Intervention , Humans , Male , Middle Aged , Treatment Outcome , Transferases , Retrospective Studies , Angina, Unstable/epidemiology , Angina, Unstable/etiology , Prognosis , Percutaneous Coronary Intervention/adverse effects , Risk Factors , Coronary Artery Disease/etiology
2.
Front Cardiovasc Med ; 10: 1196348, 2023.
Article in English | MEDLINE | ID: mdl-37396583

ABSTRACT

Background: Serum miR-183-5p levels are associated with carotid atherosclerosis, while less is known about the relationship between circulating miR-183-5p levels and stable coronary artery disease (CAD). Methods: In this cross-sectional study, consecutive patients with chest pain who underwent coronary angiograms from January 2022 to March 2022 at our center were enrolled. Those presenting acute coronary syndrome or had a prior CAD were excluded. Clinical presentations, laboratory parameters, and angiographic findings were collected. Serum miR-183-5p levels were measured using quantitative real-time polymerase chain reaction. CAD severity was displayed as the number of diseased vessels and further evaluated by the Gensini score system. Results: Overall, 135 patients (median age, 62.0 years; male, 52.6%) were included in the present study. Stable CAD was identified in 85.2% of the study population, with 45.9% having 1-vessel disease, 21.5% having 2-vessel disease, and 17.8% having 3-vessel or left main disease. Serum miR-183-5p levels were significantly increased in CAD patients with different severities than non-CAD patients (all adjusted p < 0.05). Serum miR-183-5p levels increased as tertiles of the Gensini score progressed (all adjusted p < 0.05). Importantly, serum miR-183-5p levels could predict the presence of CAD and 3-vessel or left main disease in the receiver operating characteristic curve analysis (both p < 0.01), and also in multivariate analysis adjusting for age, sex, body mass index, diabetes, hypersensitive-C-reactive protein (both p < 0.05). Conclusion: Serum miR-183-5p levels are independently and positively correlated with CAD presence and severity.

3.
Membranes (Basel) ; 12(6)2022 Jun 11.
Article in English | MEDLINE | ID: mdl-35736317

ABSTRACT

The separation of chloride and sulphate is important for the treatment of high salt wastewater, and monovalent selective electrodialysis (MSED) has advantages in terms of energy consumption and pre-treatment costs compared to nanofiltration salt separation. Most of the research on monovalent anion-selective membranes (MASM) is still on a laboratory scale due to the preparation process, cost, and other reasons. In this study, a low-cost, easy-to-operate modification scheme was used to prepare MASM, which was applied to assemble a pilot-scale electrodialysis device to treat reverse osmosis concentrated water with a salt content of 4% to 5%. The results indicate that the optimum operating conditions for the device are: 250 L/h influent flow rate for the concentration and dilute compartments, 350 L/h influent flow rate for the electrode compartment and a constant voltage of 20 V. The separation effect of the pilot electrodialysis plant at optimal operating conditions was: the Cl- and SO42- transmission rates of 80% and 2.54% respectively, the separation efficiency (S) of 93.85% and the Energy consumption per unit of NaCl (ENaCl) of 0.344 kWh/kg. The analysis of the variation of the three parameters of selective separation performance during electrodialysis indicates that the separation efficiency (S) is a suitable parameter for measuring the selective separation performance of the device compared to the monovalent selectivity coefficient (PSO42-Cl-).

SELECTION OF CITATIONS
SEARCH DETAIL